Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tiamat Sciences is a biotechnology company specializing in plant-based molecular farming to produce animal-free growth factors and proteins. By utilizing a proprietary transient expression platform in plants, the company provides a cost-effective and scalable alternative to traditional bioreactor-based production methods. Their products are primarily used in the cellular agriculture, regenerative medicine, and vaccine manufacturing sectors. Tiamat Sciences Australia serves as the regional arm, leveraging Australia's biotech ecosystem to support the global supply of high-purity, animal-free reagents. The company's mission is to significantly reduce the cost of essential raw materials for the next generation of biotechnology products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tiamat Australia.